IRIS

Sfoglia per Rivista  DIABETOLOGIA

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 38 a 57 di 128
Titolo Data di pubblicazione Autore(i) File
DETECTION OF PANCREATIC INSULITIS IN TYPE-1 DIABETES BY USING 1231I-LABELED INTERLEUKIN-2 1-gen-1992 Signore, A; Chianelli, M; Ferretti, E; Tomei, E; Ronga, G; Andreani, D; Pozzilli, P
Diet and its effect on diabetes incidence in the NOD/Ba mouse 1-gen-2000 Beales, Pe; Liddi, R; Rosignoli, G; Hill, J; Pozzilli, P
A diet rich in protein and poor in starch with reduced food intake prevents diabetes in the NOD moose: the significance of Reg gene expression in the pancreas 1-gen-2008 Guglielmi, C; Astorri, E; Portuesi, R; Bombardieri, M; Valorani, M; Pozzilli, P
Different HLA pattern in patients affected by LADA in Congo, central Africa 1-gen-2004 Guglielmi, C; Galgani, A; Anguissola, Gb; D'Avola, D; Pozzilli, P
Different HLA pattern in patients affected by LADA in Congo, central Africa 1-gen-2004 Guglielmi, C; Galgani, A; Anguissola, Gb; D'Avola, D; Pozzilli, P
Double blind trial of oral insulin in recent onset type 1 diabetes 1-gen-1999 Pitocco, D; Visalli, N; Cavallo, Mg; Bitti, Mlm; Suraci, C; Crino, A; Giordano, C; Cervoni, M; Mesturino, C; Sbriglia, Ms; Bizzarri, C; Marietti, G; Ghirlanda, G; Pozzilli, P; Grp, Is
DOUBLE-BLIND TRIAL OF NICOTINAMIDE IN RECENT-ONSET IDDM (THE IMDIAB-III STUDY) 1-gen-1995 Pozzilli, P; Visalli, N; Signore, A; Baroni, Mg; Buzzetti, R; Cavallo, Mg; Boccuni, Ml; Fava, D; Gragnoli, C; Andreani, D; Lucentini, L; Matteoli, Mc; Crino, A; Cicconetti, Ca; Teodonio, C; Paci, F; Amoretti, R; Pisano, L; Pennafina, Mg; Santopadre, G; Marozzi, G; Multari, G; Suppa, Ma; Campea, L; Demattia, Gc; Faldetta, Mc; Marietti, G; Perrone, F; Greco, Av; Ghirlanda, G
Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study 1-gen-2019 Rosenson, R. S.; Daviglus, M. L.; Handelsman, Y.; Pozzilli, P; Bays, H.; Monsalvo, M. L.; Elliott-Davey, M.; Somaratne, R.; Reaven, P.
The European C-Peptide Trial CPT: comparison of liquid mixed meal and glucagon stimulation assays for the analysis of residual beta cell function in type 1 diabetes 1-gen-2006 Mandrup-Poulsen, Tr; Battelino, T; Haastert, B; Ludvigsson, J; Pozzilli, P; Lalic, Nm; Martinez-Larrad, Mt; Mauricio, D; Philip, M; Schloot, Nc; Schober, E; Spinas, G; Vondra, K; Giani, G; Kolb, H; Grp, Cpts
Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes 1-gen-2013 Pham, Mn; Kolb, H; Battelino, T; Ludvigsson, J; Pozzilli, P; Zivehe, F; Roden, M; Mandrup-Poulsen, T; Schloot, Nc
Fasting and stimulated C-peptide at aseline in DEFEND-1, a phase 3 study of otelixizumab in new onset type 1 diabetes 1-gen-2010 Pozzilli, P; Ghirlanda, G; Brennan, Am; Belanger, B; Mckee, Cm
Fracture risk in diabetic elderly men: the MrOS study 1-gen-2014 Napoli, N; Strotmeyer Elsa, S.; Ensrud Kristine, E.; Sellmeyer Deborah, E.; Bauer Douglas, C.; Hoffman Andrew, R.; Dam Thuy-Tien, L.; Barrett-Connor, Elizabeth; Palermo, Lisa; Orwoll Eric, S.; Cummings Steven, R.; Black Dennis, M.; Schwartz Ann, V.
Free Fatty acids (FFA) and endothelial dysfunction; role of increased oxidative stress and inflammation - to: Gale EAM (2002) A missing link in the hygiene hypothesis? Diabetologia 45 : 588-592 - Comment 1-gen-2003 Beyan, H; Valorani, Mg; Pozzilli, P
Free time activities and blood glucose control in patients with type 1 diabetes 1-gen-2008 Bizzarri, C; Benevento, D; Pitocco, D; Crino, A; Spera, S; Tubili, C; Costanza, F; Maurizi, A; Cipolloni, L; Faldetta, Rc; Cappa, M; Pozzilli, P; Grp, I
GAD and IA-2 antibodies in relation to disease presentation and C-peptide secretion 1-gen-1996 Faldetta, Mc; Visalli, N; Cavallo, Mg; Andreani, D; Leslie, Rdg; Hava, M; Pozzilli, P
The GETREM study: New preliminary findings for the clinical remission in IDDM using logistic regression 1-gen-1997 Rowne, Pd; Lampeter, E; Deleeuw, I; Iafusco, D; Ionescutirgoviste, C; Kolouskova, S; Linn, T; Ludvigsson, J; Madascy, L; Mrozikiewicz, A; Podar, T; Prisco, M; Vavrinec, J; Vialettes, B; Visalli, N; Yilmaz, T; Pozzilli, P
Glucose RapidSpray (TM) for a new management of hypoglycaemia in children up to 5 years of age with type 1 diabetes 1-gen-2008 Pronina, E; Petraikina, H; Antsiferov, M; Duchareva, O; Guglielmi, C; Khazrai, M; Pozzilli, P
High and standard dose of nicotinamide in recent onset insulin dependent diabetes (the IMDIAB 6 Study) 1-gen-1998 Visalli, N; Ghirlanda, G; Pozzilli, P; Grp, Is.
HLA and insulin genes: Bayesian networks confirm interaction between the two most important susceptibility genes in type 1 diabetes in a French caucasian population 1-gen-2010 Portuesi, R; Bohm, Bo; Julier, C; Pozzilli, P
HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus 1-gen-2013 Strollo, R; Rizzo, P; Spoletini, M; Landy, R; Hughes, C; Ponchel, F; Napoli, N; Palermo, A; Buzzetti, R; Pozzilli, P; Nissim, A
Mostrati risultati da 38 a 57 di 128
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile